title: Expression of cytokeratins in glioblastoma multiforme.
abstract: Little is known about the cytokeratin (CK) expressions in glioblastoma multiforme (GBM). The aim is to explore the CK expression in GM using immunohistochemistry (IHC). IHC study in 30 cases (median = 68 years, SE = 12.6) of GBM in brain. CK expression using AE1/3 antidody was seen in 29/30 (97 %) cases. There were no expressions of CK34BE12, CK5, CK6, CK7, CK8, CK14, CK 18, CK19, and CK20. Expression of p53 and glial fibrillary acidic protein (GFAP) were recognized in all 30 cases (100 %). All cases showed Ki-67 antigen labeling, index of which ranged from 6 to 43 % (m ± SD = 24 + 16). The IHC using CKAE1/3 in GBM very frequently shows positive reaction. The expression may cause difficulty in pathologic diagnosis in GBM, particularly in discrimination between GBM and metastatic carcinoma. The CK positivity in GM may be due to CK molecules other than CK34BE12, CK5, CK6, CK7, CK8, CK14, CK18, CK19 and CK20. GBM frequently expression p53 and high Ki-67 labeling.
authors: Department of Pathology, Shizuoka City Shimizu Hospital, Miyakami 1231, Shimizu-Ku, Shizuoka, 424-8636, Japan, piyo0111jp@yahoo.co.jp.
authors: Tadashi
authors: T
authors: Terada
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001932:Brain Neoplasms / Q000378:metabolism* / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D005909:Glioblastoma / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D007124:Immunoenzyme Techniques; D007633:Keratins / Q000378:metabolism*; D019394:Ki-67 Antigen / Q000378:metabolism*; D008297:Male; D060787:Neoplasm Grading; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen; D007633:Keratins
references: Am J Surg Pathol. 1989 Feb;13(2):141-5
references: 2464954
references: Cancer Res. 2011 Jul 1;71(13):4550-61
references: 21555372
references: Pathol Int. 2002 Nov;52(11):740-6
references: 12685552
references: Indian J Pathol Microbiol. 2007 Jul;50(3):478-81
references: 17883112
references: Oncol Rep. 2012 Mar;27(3):707-13
references: 22024963
references: Clin Neuropathol. 1994 Jan-Feb;13(1):1-11
references: 7518371
references: Mod Pathol. 1993 May;6(3):342-7
references: 7688463
references: Histopathology. 1989 Apr;14(4):359-68
references: 2472343
references: Arch Pathol Lab Med. 1999 Oct;123(10):917-20
references: 10506444